ARTICLE | Distillery Therapeutics
Blocking glucocorticoid signaling to increase checkpoint inhibitor sensitivity
September 29, 2020 12:53 AM UTC
DISEASE CATEGORY: Cancer
INDICATION: Melanoma; colorectal cancer...
BCIQ Company Profiles
DISEASE CATEGORY: Cancer
INDICATION: Melanoma; colorectal cancer...
BCIQ Company Profiles